Header Logo

Connection

DAVID ALLISON to Weight Loss

Back to Details
This is a "connection" page, showing publications DAVID ALLISON has written about Weight Loss.
DAVID ALLISON
Connection Strength
8.124
Weight Loss
  1. Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study. Obesity (Silver Spring). 2026 Mar; 34(3):729-737.
    View in: PubMed
    Score: 0.715
  2. Measurement rigor is not a substitute for design rigor in causal inference: increased physical activity does cause (modest) weight loss. Int J Obes (Lond). 2023 01; 47(1):3-4.
    View in: PubMed
    Score: 0.579
  3. Change in study randomization allocation needs to be included in statistical analysis: comment on 'Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study'. Breast Cancer Res Treat. 2019 05; 175(1):263-264.
    View in: PubMed
    Score: 0.445
  4. Weight Cycling Increases Longevity Compared with Sustained Obesity in Mice. Obesity (Silver Spring). 2018 11; 26(11):1733-1739.
    View in: PubMed
    Score: 0.437
  5. Weighing the Evidence of Common Beliefs in Obesity Research. Crit Rev Food Sci Nutr. 2015; 55(14):2014-53.
    View in: PubMed
    Score: 0.335
  6. Energy intake and weight loss. JAMA. 2014 Dec 24-31; 312(24):2687-8.
    View in: PubMed
    Score: 0.333
  7. Predicting adult weight change in the real world: a systematic review and meta-analysis accounting for compensatory changes in energy intake or expenditure. Int J Obes (Lond). 2015 Aug; 39(8):1181-7.
    View in: PubMed
    Score: 0.330
  8. Association of run-in periods with weight loss in obesity randomized controlled trials. Obes Rev. 2014 Jan; 15(1):68-73.
    View in: PubMed
    Score: 0.307
  9. Randomized controlled trial of the Medifast 5 & 1 Plan for weight loss. Int J Obes (Lond). 2013 Dec; 37(12):1571-8.
    View in: PubMed
    Score: 0.297
  10. Myths, presumptions, and facts about obesity. N Engl J Med. 2013 Jan 31; 368(5):446-54.
    View in: PubMed
    Score: 0.293
  11. No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight. Int J Obes (Lond). 2011 May; 35(5):652-7.
    View in: PubMed
    Score: 0.252
  12. Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One. 2009 Aug 13; 4(8):e6624.
    View in: PubMed
    Score: 0.231
  13. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond). 2008 Oct; 32(10):1531-6.
    View in: PubMed
    Score: 0.215
  14. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev. 2008 May; 9(3):219-35.
    View in: PubMed
    Score: 0.211
  15. Intentional weight loss reduces mortality rate in a rodent model of dietary obesity. Obes Res. 2005 Apr; 13(4):693-702.
    View in: PubMed
    Score: 0.170
  16. The effects of intentional weight loss as a latent variable problem. Stat Med. 2005 Mar 30; 24(6):941-54.
    View in: PubMed
    Score: 0.170
  17. Impact of sustained calorie restriction and weight cycling on body composition in high-fat diet-fed male and female C57BL/6J mice. Obesity (Silver Spring). 2024 May; 32(5):959-968.
    View in: PubMed
    Score: 0.159
  18. Incorrect analysis in "Effects of the application of a food processing-based classification system in obese women: A randomized controlled pilot study" has resulted in incorrect conclusions of demonstrated effects where no such effects have been demonstrated. Nutr Health. 2026 Jan; 32(1):27-29.
    View in: PubMed
    Score: 0.153
  19. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr. 2003 Apr; 57(4):514-22.
    View in: PubMed
    Score: 0.148
  20. Weight loss causes increased mortality: cons. Obes Rev. 2003 Feb; 4(1):9-16.
    View in: PubMed
    Score: 0.147
  21. Long-acting amylin analogue for weight reduction. Lancet. 2021 12 11; 398(10317):2132-2134.
    View in: PubMed
    Score: 0.135
  22. Randomized trial of a novel lifestyle intervention compared with the Diabetes Prevention Program for weight loss in adult dependents of military service members. Am J Clin Nutr. 2021 10 04; 114(4):1546-1559.
    View in: PubMed
    Score: 0.134
  23. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr. 2001 Jan; 41(1):1-28; discussion 39-40.
    View in: PubMed
    Score: 0.127
  24. Efficacy and safety of a specific commercial high-protein meal-replacement product line in weight management: meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022; 62(3):798-809.
    View in: PubMed
    Score: 0.125
  25. Neglecting regression to the mean continues to lead to unwarranted conclusions: Letter regarding "The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial". Adv Clin Exp Med. 2019 Nov; 28(11):1569-1570.
    View in: PubMed
    Score: 0.117
  26. Is the prevalence of successful weight loss and maintenance higher in the general community than the research clinic? Obes Res. 1999 Jul; 7(4):407-13.
    View in: PubMed
    Score: 0.114
  27. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999 Jun; 23(6):603-11.
    View in: PubMed
    Score: 0.114
  28. Predicting treatment attendance and weight loss: assessing the psychometric properties and predictive validity of the Dieting Readiness Test. J Pers Assess. 1997 Feb; 68(1):173-83.
    View in: PubMed
    Score: 0.097
  29. Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trials. Int J Obes (Lond). 2016 06; 40(6):895-8.
    View in: PubMed
    Score: 0.088
  30. A randomised placebo-controlled clinical trial of an acupressure device for weight loss. Int J Obes Relat Metab Disord. 1995 Sep; 19(9):653-8.
    View in: PubMed
    Score: 0.088
  31. Increased fruit and vegetable intake has no discernible effect on weight loss: a systematic review and meta-analysis. Am J Clin Nutr. 2014 Aug; 100(2):567-76.
    View in: PubMed
    Score: 0.081
  32. The effectiveness of breakfast recommendations on weight loss: a randomized controlled trial. Am J Clin Nutr. 2014 Aug; 100(2):507-13.
    View in: PubMed
    Score: 0.080
  33. Empirical evidence does not support an association between less ambitious pre-treatment goals and better treatment outcomes: a meta-analysis. Obes Rev. 2013 Jul; 14(7):532-40.
    View in: PubMed
    Score: 0.074
  34. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb; 95(2):297-308.
    View in: PubMed
    Score: 0.068
  35. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012 Feb; 20(2):330-42.
    View in: PubMed
    Score: 0.067
  36. Meta-analysis of studies of a specific delivery mode for a modified-carbohydrate diet. J Hum Nutr Diet. 2011 Dec; 24(6):525-35.
    View in: PubMed
    Score: 0.067
  37. Sample size in obesity trials: patient perspective versus current practice. Med Decis Making. 2010 Jan-Feb; 30(1):68-75.
    View in: PubMed
    Score: 0.058
  38. Effects of a reimbursement incentive on enrollment in a weight control program. Obesity (Silver Spring). 2007 Nov; 15(11):2733-8.
    View in: PubMed
    Score: 0.051
  39. Obesity: person and population. Obesity (Silver Spring). 2006 Jul; 14 Suppl 4:156S-159S.
    View in: PubMed
    Score: 0.046
  40. Effectiveness of a digital weight management program on diet quality: a randomized controlled trial. Am J Clin Nutr. 2025 Sep; 122(3):830-840.
    View in: PubMed
    Score: 0.043
  41. Dietary supplements in weight reduction. J Am Diet Assoc. 2005 May; 105(5 Suppl 1):S80-6.
    View in: PubMed
    Score: 0.043
  42. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004 Nov; 28(11):1411-9.
    View in: PubMed
    Score: 0.041
  43. Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19. Contemp Clin Trials. 2024 05; 140:107490.
    View in: PubMed
    Score: 0.040
  44. Effects of outcome-driven insurance reimbursement on short-term weight control. Int J Obes Relat Metab Disord. 2003 Nov; 27(11):1423-9.
    View in: PubMed
    Score: 0.039
  45. Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction. Expert Rev Endocrinol Metab. 2023 Sep-Nov; 18(4):307-319.
    View in: PubMed
    Score: 0.037
  46. Randomized controlled trial of a novel lifestyle intervention used with or without meal replacements in work sites. Obesity (Silver Spring). 2023 02; 31(2):374-389.
    View in: PubMed
    Score: 0.037
  47. Treatment and prevention of obesity: what works, what doesn't work, and what might work. Lipids. 2003 Feb; 38(2):147-55.
    View in: PubMed
    Score: 0.037
  48. Sexual dimorphism in the energy content of weight change. Int J Obes Relat Metab Disord. 2002 Oct; 26(10):1339-48.
    View in: PubMed
    Score: 0.036
  49. Stimulated Insulin Secretion Predicts Changes in Body Composition Following Weight Loss in Adults with High BMI. J Nutr. 2022 03 03; 152(3):655-662.
    View in: PubMed
    Score: 0.034
  50. Effectiveness of a lifestyle weight-loss intervention targeting inactive former elite athletes: the Champ4Life randomised controlled trial. Br J Sports Med. 2022 Apr; 56(7):394-401.
    View in: PubMed
    Score: 0.033
  51. Novel mathematical models for investigating topics in obesity. Adv Nutr. 2014 Sep; 5(5):561-2.
    View in: PubMed
    Score: 0.020
  52. Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. Am J Clin Nutr. 1994 Aug; 60(2):249-54.
    View in: PubMed
    Score: 0.020
  53. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1596-600.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.